244
Beleave is now strongly positioned to put their findings to the test. As reported on December 4th, 2017, the company was granted their oil production license under Health Canada. As their R&D projects conclude, one could expect that their extraction initiatives will be prioritized and rapidly scaled, either independently or through partnerships with peers.
A problem that many cannabis companies and research organizations have been racing to solve is that of bioavailability. With most cannabis products in the marketplace today, a significant amount of the active compounds are not abosrbed or processed by the body which can lead to inprecise dosing. Beleave plans to address this issue through a research initiative announced on October 24, 2017. The company has entered into a collaboration with highly accomplished Dr. Michael Rogers, an associate professor at the University of Guelph’s Department of Food Sciences. The goal of the program is to develop proprietary delivery systems with increased bioavailability. If successful, this technology could prove to be greatly rewarding for the company in the upcoming recreational market.
Beleave’s unique offering and positioning in the Canadian cannabis sector should not be overlooked by investors. The company is expected to receive their dried cannabis sales license in the nearterm, and commence sales shortly after. With their greenhouse project anticipated to be operational in the second half of 2018, the company is well positioned to supply medical patients as well as the upcoming adult use market. The company’s growing portfolio of intellectual property could also provide significant value as new consumption methods become available in 2018 and beyond.
For those who wish to learn more about Beleave, check out their website at beleave.com.
Feel free to follow me on Twitter @weady28
Highlights:
- Build out of 80k sq. ft. hybrid greenhouse
- Ryerson University R&D projects
- Tight share structure & strong insider ownership
- Cannabis Wheaton production partnership
- Research in cannabis food & drug delivery
- On December 4th, BE received its license to produce oils
http://thecse.com/sites/default/files/Beleave_and_Ryerson_Develop_Unique_Approach_for_Cannabinoid_Extraction_and_Recovery.pdf
http://thecse.com/sites/default/files/Beleave-Marshall_Press_Release_Mar6.pdf
https://globenewswire.com/news-release/2017/10/24/1152252/0/en/Beleave-and-Dr-Michael-Rogers-Begin-Research-in-Cannabis-Food-and-Drug-Delivery.html
https://globenewswire.com/news-release/2017/11/20/1197382/0/en/Beleave-Announces-5-Million-Non-Brokered-Private-Placement-of-Units.html
http://www.stockhouse.com/news/press-releases/2017/10/05/cannabis-wheaton-and-beleave-sign-definitive-agreement-for-up-to-10-000-000-in
http://www.marketwired.com/press-release/-2242405.htm
https://globenewswire.com/news-release/2017/12/04/1220334/0/en/Beleave-Receives-License-to-Produce-Cannabis-Oils-from-Health-Canada.html